Novavax targets $230M-$270M 2026 adjusted revenue while refining 2028 opex to $150M-$200M (NASDAQ:NVAX)
诺瓦(US:NVAX) Seeking Alpha·2026-05-07 02:23To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...